Page last updated: 2024-08-23

acetylgalactosamine and Chagas Cardiomyopathy

acetylgalactosamine has been researched along with Chagas Cardiomyopathy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allahdadi, KJ; Aragão França, L; Azevedo, CM; Carvalho, RH; da Silva, KN; de Souza Neto, JD; Dos Santos, RR; Macambira, SG; Meira, CS; Neto, PC; Paredes, BD; Sampaio, GLA; Silva, DN; Soares, MBP; Souza, BSF; Tavora, F; Vasconcelos, JF1

Other Studies

1 other study(ies) available for acetylgalactosamine and Chagas Cardiomyopathy

ArticleYear
Association of Cardiac Galectin-3 Expression, Myocarditis, and Fibrosis in Chronic Chagas Disease Cardiomyopathy.
    The American journal of pathology, 2017, Volume: 187, Issue:5

    Topics: Acetylgalactosamine; Animals; Cell Proliferation; Cell Survival; Chagas Cardiomyopathy; Chronic Disease; Collagen Type I; Fibrosis; Galectin 3; Heart Transplantation; Humans; Macrophages; Mice; Mice, Inbred C57BL; Myocarditis; Myocardium; Myofibroblasts; T-Lymphocytes

2017